Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTay, Hui Minen
dc.contributor.authorHou, Han Weien
dc.contributor.authorDalan, Rinkooen
dc.contributor.authorBoehm, Bernhard Ottoen
dc.identifier.citationHou, H. W., Tay, H. M., Dalan, R., & Boehm, B. O. (2017). Advances in Neutrophil Testing In Type 2 Diabetes Mellitus. Current Research in Diabetes & Obesity Journal, 1(5), 555572-.en
dc.description.abstractPatients with type 2 diabetes mellitus (T2DM) suffer from impaired glucose metabolism which results in low-grade inflammation and activation of the innate immune system. Neutrophils the key effector cells of the innate immune system and heavily implicated in the pathogenesis of T2DM, are promising cell-based inflammatory biomarkers for immune health profiling, provided that they can be rapidly purified and measured with sufficient precision. In this review, we highlight recent advances in neutrophil isolation and functional assay using microfluidics technologies and the potential of their functional phenotype as a novel biomarker of vascular risk in diabetes.en
dc.description.sponsorshipMOE (Min. of Education, S’pore)en
dc.description.sponsorshipNMRC (Natl Medical Research Council, S’pore)en
dc.format.extent5 p.en
dc.relation.ispartofseriesCurrent Research in Diabetes & Obesity Journalen
dc.rightsThis work is licensed under Creative Commons Attribution 4.0 Licenseen
dc.titleAdvances in Neutrophil Testing In Type 2 Diabetes Mellitusen
dc.typeJournal Articleen
dc.contributor.schoolLee Kong Chian School of Medicine (LKCMedicine)en
dc.description.versionPublished versionen
item.fulltextWith Fulltext-
Appears in Collections:LKCMedicine Journal Articles
Files in This Item:
File Description SizeFormat 
CRDOJ.MS.ID.555572.pdf554.45 kBAdobe PDFThumbnail

Page view(s) 5

Updated on Dec 6, 2022

Download(s) 20

Updated on Dec 6, 2022

Google ScholarTM


Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.